Direct and efficient liquid chromatographic-tandem mass spectrometric method for opiates in urine drug testing - importance of 6-acetylmorphine and reduction of analytes

Drug Testing and Analysis

Volumn 6, Issue 4, 2014, Pages 317-324

  Andersson, Maria ^a   Stephanson, Nikolai ^a   Öhman, Inger ^a   Terzuoli, Tommy ^a   Lindh, Jonatan D ^a   Beck, Olof ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

6 acetylmorphine; Interpretation; LC MS MS; Opiates; Urine

Indexed keywords

BODY FLUIDS; DRUG PRODUCTS; GAS CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; SCREENING;

6-ACETYLMORPHINE; ANALYTES; DRUG TESTING; GLUCURONIDES; INTERPRETATION; LC-MS-MS; LC.MS/MS; MORPHINE-3-GLUCURONIDE; OPIATE; URINE;

DIRECT INJECTION;

CODEINE; CODEINE 6 GLUCURONIDE; DIAMORPHINE; MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 ACETATE; MORPHINE 6 GLUCURONIDE; OPIATE; 6-O-MONOACETYLMORPHINE; MORPHINE DERIVATIVE; NARCOTIC ANALGESIC AGENT;

ACCURACY; ANALYTIC METHOD; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG URINE LEVEL; ELECTROSPRAY; HUMAN; IMMUNOCHEMISTRY; LIMIT OF DETECTION; LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; TANDEM MASS SPECTROMETRY; URINE; VALIDITY; METABOLISM; PROCEDURES; SUBSTANCE ABUSE; URINALYSIS; VALIDATION STUDY;

ANALGESICS, OPIOID; CHROMATOGRAPHY, LIQUID; HUMANS; LIMIT OF DETECTION; MORPHINE DERIVATIVES; SUBSTANCE ABUSE DETECTION; TANDEM MASS SPECTROMETRY; URINALYSIS;

EID: 84898473556     PISSN: 19427603     EISSN: 19427611     Source Type: Journal    
DOI: 10.1002/dta.1486     Document Type: Article

References (38)

1. E. J. Rook, A. D. Huitema, W. van den Brink, J.M. van Ree, J.H. Beijnen Pharmacokinetics and pharmacokinetic variability of heroin and its metabolites: Review of the literature. Curr. Clin. Pharmacol. 2006, 1, 109.
2. H.H. Maurer, C. Sauer, D.S. Theobald Toxicokinetics of drugs of abuse: Current knowledge of the isoenzymes involved in the human metabolism of tetrahydrocannabinol, cocaine, heroin, morphine, and codeine. Ther. Drug Monit. 2006, 28, 447.
3. R. A. Braithwaite, D.R. Jarvie, P.S. Minty, D. Simpson, B. Widdop Screening for drugs of abuse. I: Opiates, amphetamines and cocaine. Ann. Clin. Biochem. 1995, 32, 123.
4. M. Stefanidou, S. Athanaselis, C. Spiliopoulou, A. Dona, C. Maravelias Biomarkers of opiate use. Int. J. Clin. Pract. 2010, 64, 1712.
5. E. Kaa Street drugs in Denmark. J. Forensic Sci. 1991, 36, 866.
6. C. L. Oneal, A. Poklis Simultaneous determination of acetylcodeine, monoacetylmorphine, and other opiates in urine by GC-MS. J. Anal. Toxicol. 1997, 21, 427.
7. E.J. Cone, P. Welch, J.M. Mitchell, B.D. Paul Forensic drug-testing for opiates: I. Detection of 6-acetylmorphine in urine as an indicator of recent heroin exposure; drug and assay considerations and detection times. J. Anal. Toxicol. 1991, 15, 1.
8. B.L. Coffman, G.R. Rios, C.D. King, T.R. Tephly Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab. Dispos. 1997, 25, 1.
9. M.D. Green, C.D. King, B. Mojarrabi, P.I. Mackenzie, T.R. Taphly Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3. Drug Metab. Dispos. 1998, 26, 507.
10. C.C. Faura, S.L. Collins, R.A. Moore, H.J. McQuay Systematic review of factors affecting the ratios of morphine and its major metabolites. Pain 1998, 74, 43.
11. M.R. Meyer, H.H. Maurer Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse. Pharmacogenomics 2011, 12, 215.
12. R. Dams, C.M. Murphy, R.E. Choo, W.E. Lambert, A.P. De Leenheer, M.A. Huestis LC-atmospheric pressure chemical ionization-MS/MS analysis of multiple illicit drugs, methadone, and their metabolites in oral fluid following protein precipitation. Anal. Chem. 2003, 75, 798.
13. M. Tatsuno, M. Nishikawa, H. Tsuchihashi, I. Igarashi, F. Kasuya, M. Fukui Thermospray and atmospheric pressure chemical ionization liquid chromatographic mass spectrometric analysis of benzodiazepines and their metabolites. Jpn. J. Toxicol. Environ. Health 1996, 42, 248.
14. M.J. Bogusz, R.D. Maier, M. Erkens, S. Driessen Determination of morphine and its 3- and 6-glucuronides, codeine, codeine-glucuronide and 6-monoacetylmorphine in body fluids by liquid chromatography atmospheric pressure chemical ionization mass spectrometry. J. Chromatogr. B Biomed. Sci. Appl. 1997, 703, 115.
15. L.E. Edinboro, R.C. Backer, A. Poklis Direct analysis of opiates in urine by liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 2005, 29, 704.
16. C.M. Murphy, M.A. Huestis LC-ESI-MS/MS analysis for the quantification of morphine, codeine, morphine-3-beta-d-glucuronide, morphine-6-beta-d-glucuronide, and codeine-6-beta-d-glucuronide in human urine. J. Mass Spectrom. 2005, 40, 1412.
17. R. Coles, M.M. Kushnir, G.J. Nelson, G.A. McMillin, F.M. Urry Simultaneous determination of codeine, morphine, hydrocodone, hydromorphone, oxycodone, and 6-acetylmorphine in urine, serum, plasma, whole blood, and meconium by LC-MS/MS. J. Anal. Toxicol. 2007, 31, 1.
18. J. Feng, L. Wang, I. Dai, T. Harmon, J.T. Bernert Simultaneous determination of multiple drugs of abuse and relevant metabolites in urine by LC-MS/MS. J. Anal. Toxicol. 2007, 31, 359.
19. A.D. de Jager, N.L. Bailey Online extraction LC-MS/MS method for the simultaneous quantitative confirmation of urine drugs of abuse and metabolites: Amphetamines, opiates, cocaine, cannabis, benzodiazepines and methadone. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2011, 879, 2642.
20. W.C. Cheng, T.S. Yau, M.K. Wong, L.P. Chan, V.K. Mok A high-throughput urinalysis of abused drugs based on a SPE-LC-MS/MS method coupled with an in-house developed post-analysis data treatment system. Forensic Sci. Int. 2006, 162, 95.
21. E.J. Fox, S. Twigger, K.R. Allen Criteria for opiate identification using liquid chromatography linked to tandem mass spectrometry: Problems in routine practice. Ann. Clin. Biochem. 2009, 46, 50.
22. E. Gustavsson, M. Andersson, N. Stephanson, O. Beck Validation of direct injection electrospray lc-ms/ms for confirmation of opiates in urine drug testing. J. Mass Spectrom. 2007, 42, 881.
23. J.O. Svensson, M. Andersson, E. Gustavsson, O. Beck Electrospray LC-MS method with solid-phase extraction for accurate determination of morphine-, codeine-, and ethylmorphine-glucuronides and 6-acetylmorphine in urine. J. Anal. Toxicol. 2007, 31, 81.
24. B. Maralikova, W. Weinmann Confirmatory analysis for drugs of abuse in plasma and urine by high-performance liquid chromatography-tandem mass spectrometry with respect to criteria for compound identification. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2004, 811, 21.
25. P. Marquet, G. Lachatre Liquid chromatography-mass spectrometry: Potential in forensic and clinical toxicology. J. Chromatogr. B 1999, 733, 93.
26. H.H. Maurer Perspectives of liquid chromatography coupled to low- and high-resolution mass spectrometry for screening, identification, and quantification of drugs in clinical and forensic toxicology. Ther. Drug Monit. 2010, 32, 324.
27. F.T. Peters Recent advances of liquid chromatography-(tandem) mass spectrometry in clinical and forensic toxicology. Clin. Biochem. 2011, 44, 54.
28. M.I. Churchwell, N.C. Twaddle, L.R. Meeker, D.R. Doerge Improving LC-MS sensitivity through increases in chromatographic performance: Comparisons of UPLC-ES/MS/MS to HPLC-ES/MS/MS. J. Chromatogr. B-Anal. Technol. Biomed. Life Sci. 2005, 825, 134.
29. M. Andersson, T. Janosik, H. Shirani, J. Slatt, A. Fischer, O. Beck Synthesis and bioanalytical evaluation of morphine-3-O-sulfate and morphine-6-O-sulfate in human urine and plasma using LC-MS/MS. J. Separate. Sci. 2012, 35, 367.
30. R Development Core Team. R a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2010.
31. E. Stokvis, H. Rosing, J.H. Beijnen Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography/mass spectrometry: necessity or not?. Rapid Commun. Mass Spectrom 2005, 19, 401.
32. P.L. Tenore Advanced urine toxicology testing. J. Addict. Dis. 2010, 29, 436.
33. H.N. elSohly, D.F. Stanford, A.B. Jones, M.A. elSohly, H. Snyder, C. Pedersen Gas chromatographic/mass spectrometric analysis of morphine and codeine in human urine of poppy seed eaters. J. Forensic Sci. 1988, 33, 347.
34. D.C. Fuller A statistical approach to the prediction of verifiable heroin use from total codeine and total morphine concentrations in urine. J. Forensic Sci. 1997, 42, 685.
35. O. Beck, M. Bottcher Paradoxical results in urine drug testing for 6-acetyl morphine and total opiates: Implications for best analytical strategy. J. Anal. Toxicol. 2006, 30, 73.
36. D.W. Lachenmeier, C. Sproll, F. Musshoff Poppy seed foods and opiate drug testing--where are we today? Ther. Drug Monit. 2010, 32, 11.
37. L. Bertilsson Metabolism of antidepressant and neuroleptic drugs by cytochrome p450s: Clinical and interethnic aspects. Clin. Pharmacol. Ther. 2007, 82, 606.
38. J. Kirchheiner, H. Schmidt, M. Tzvetkov, J.T. Keulen, J. Lotsch, I. Roots, J Brockmoller Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication. Pharmacogenomics J. 2007, 7, 257.